Trial intelligence / Profile preview

Intraprostatic Botox for chronic prostatitis / chronic pelvic pain syndrome

2007-001602-24Phase 3Completed

Sponsor
Justus Liebig University Giessen
Start
Jun 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial of botulinum toxin type A in Prostatodynia (CP/CPPS) (2 arms), sponsored by Justus Liebig University Giessen. Primary endpoint: Primary: Reduction in NIH-CPSI score at 3 months. Started Jun 2009; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

Prostatodynia (CP/CPPS)

Beyond the preview

Go deeper on 2007-001602-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-001602-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call